Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus

Journal of Clinical Investigation

Volumn 112, Issue 8, 2003, Pages 1211-1222

  Zeng, Defu ^a,c   Liu, Yinping ^a   Sidobre, Stephane ^b   Kronenberg, Mitchell ^b   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIBODY; AUTOANTIBODY; CD4 ANTIGEN; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD1D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; KILLER CELLS, NATURAL; LUPUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NZB; TH1 CELLS;

EID: 0347988004     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317165     Document Type: Article

References (64)

1. Kotzin, B.L. 1996. Systemic lupus erythematosus. Cell. 85:303-306.
2. Theofilopoulos, A.N., Kofler, R., Singer, P.A., and Dixon, F.J. 1989. Molecular genetics of murine lupus models. Adv. Immunol. 46:61-109.
3. Hahn, B.H. 1998. Antibodies to DNA. N. Engl. J. Med. 338:1359-1368.
4. O'Keefe, T.L., Datta, S.K., and Imanishi-Kari, T. 1992. Cationic residues in pathogenic anti-DNA autoantibodies arise by mutations of a germline gene that belongs to a large VH gene subfamily. Eur. J. Immunol. 22:619-624.
5. Via, C.S., and Shearer, G.M. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today. 9:207-213.
6. Satoh, M., and Reeves, W.H. 1994. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180:2341-2346.
7. Mendlovic, S., et al. 1988. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. U. S. A. 85:2260-2264.
8. Zeng, D., et al. 1998. Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J. Exp. Med. 187:525-536.
9. Ando, D.G., Sercarz, E.E., and Hahn, B.H. 1987. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J. Immunol. 138:3185-3190.
10. Borchers, A., Ansari, A.A., Hsu, T., Kono, D.H., and Gershwin, M.E. 2000. The pathogenesis of autoimmunity in New Zealand mice. Semin. Arthritis Rheum. 29:385-399.
11. Sobel, E.S., et al. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441-1449.
12. Roths, J.B., Murphy, E.D., and Eicher, E.M. 1984. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1-20.
13. Wofsy, D., Kerger, C.E., and Seaman, W.E. 1984. Monocytosis in the BXSB model for systemic lupus erythematosus. J. Exp. Med. 159:629-634.
14. Tsao, B.P., et al. 1990. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J. Clin. Invest. 85:530-540.
15. Theofilopoulos, A.N. 1992. Murine models of systemic lupus erythematosus. In Systemic lupus erythematosus. R.G. Lahita, editor. Churchill Livingstone. New York, New York, USA. 121 pp.
16. Wofsy, D., and Seaman, W.E. 1985. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378-391.
17. Mohan, C., Adams, S., Stanik, V., and Datta, S.K. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
18. Ebling, F.M., Tsao, B.P., Singh, R.R., Sercarz, E., and Hahn, B.H. 1993. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus. Arthritis Rheum. 36:355-364.
19. Singh, R.R., et al. 1995. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181:2017-2027.
20. Zeng, D., Lee, M.K., Tung, J., Brendolan, A., and Strober, S. 2000. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164:5000-5004.
21. Jacob, C.O., van der Meide, P.H., and McDevitt, H.O. 1987. In vivo treatment of (NZB x NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J. Exp. Med. 166:798-803.
22. Engleman, E.G., et al. 1981. Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum. 24:1396-1402.
23. Datta, S.K., Patel, H., and Berry, D. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165:1252-1268.
24. Snapper, C.M., and Paul, W.E. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236:944-947.
25. Stevens, T.L., et al. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334:253-258.
26. Mendiratta, S.K., et al. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
27. Porcelli, S.A. 1995. The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59:1-98.
28. Bendelac, A., Rivera, M.N., Park, S.H., and Roark, J.H. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
29. Kawano, T., et al. 1997. CD1d-restricted and TCR-mediated activation of Valpha 14 NKT cells by glycosylceramides. Science. 278:1626-1629.
30. Joyce, S., et al. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 279:1541-1544.
31. Gumperz, J.E., et al. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211-221.
32. Burdin, N., Brossay, L., and Kronenberg, M. 1999. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014-2025.
33. Singh, N., et al. 1999. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. Immunol. 163:2373-2377.
34. Hong, S., et al. 2001. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052-1056.
35. Sharif, S., et al. 2001. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7:1057-1062.
36. Wang, B., Geng, Y.B., and Wang, C.R. 2001. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194:313-320.
37. Jahng, A.W., et al. 2001. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1789-1799.
38. Naumov, Y.N., et al. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. U. S. A. 98:13838-13843.
39. + T cells in the bone marrow: divergence from the thymus. J. Immunol. 163:5338-5345.
40. + T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189:1073-1081.
41. Zeng, D., et al. 2002. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood. 99:1449-1457.
42. Matsuda, J.L., et al. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-754.
43. Brossay, L., et al. 1997. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159:1216-1224.
44. Cui, J., et al. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J. Exp. Med. 190:783-792.
45. Coffman, R.L., Lebman, D.A., and Rothman, P. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:229-270.
46. Steward, M.W., and Hay, F.C. 1976. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin. Exp. Immunol. 26:363-370.
47. Reininger, L., et al. 1996. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. J. Exp. Med. 184:853-861.
48. Samuelsson, A., Towers, T.L., and Ravetch, J.V. 2001. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 291:484-486.
49. Clynes, R., et al. 1999. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:179-185.
50. Szalay, G., et al. 1999. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol. 162:6955-6958.
51. Benlagha, K., Kyin, T., Beavis, A., Teyton, L., and Bendelac, A. 2002. A thymic precursor to the NK T cell lineage. Science. 296:553-555.
52. + CD1d-dependent precursor stage. J. Exp. Med. 195:835-844.
53. Gadue, P., and Stein, P.L. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169:2397-2406.
54. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112-5119.
55. Amano, M., et al. 1998. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beca 2-microglobulin-dependent and independent forms. J. Immunol. 161:1710-1717.
56. Roark, J.H., et al. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:3121-3127.
57. Peng, S.L., Moslehi, J., and Craft, J. 1997. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936-1946.
58. Santiago, M.L., et al. 1997. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185:65-70.
59. Miyamoto, K., Miyake, S., and Yamamura, T. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531-534.
60. Carnaud, C., et al. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650.
61. Amigorena, S., Bonnerot, C., Fridman, W.H., and Teillaud, J.L. 1990. Recombinant: interleukin 2-activated natural killer cells regulate IgG2a production. Eur. J. Immunol. 20:1781-1787.
62. Wilder, J.A., Koh, C.Y., and Yuan, D. 1996. The role of NK cells during in vivo antigen-specific antibody responses. J. Immunol. 156:146-152.
63. Racke, F.K., Clare-Salzer, M., and Wilson, S.B. 2002. Control of myeloid dendritic cell differentiation and function by CD1d-restricted (NK) T cells. Front. Biosci. 7:d978-d985.
64. Hong, S., et al. 2001. Genetic deletion of CD1 in lupus: evidence of a regulatory role. Arthritis Rheum. 44(Suppl.):283. (Abstr.)